Roche Media 9. Jan. 2026 Roche returns to Chinese biotech MediLink for another ADC pact - Endpoints News
FierceBiotech 9. Jan. 2026 Roche returns to MediLink with promise of $570M near-term payments for another ADC
Roche Media 9. Jan. 2026 Roche returns to MediLink with $570M near-term payments for ADC - Fierce Biotech
Endpoints News 8. Jan. 2026 Ollin’s drug clears retinal disease better than Roche’s Vabysmo in Phase 1b trial
Endpoints News 8. Jan. 2026 Charles Fuchs leaves Roche to steer ADC pipeline at Tubulis shortly after $401M Series C
FierceBiotech 6. Jan. 2026 In Structure licensing deal, Roche commits $100M to shore up GLP-1 position
Roche Media 6. Jan. 2026 In Structure licensing deal, Roche commits $100M to shore up GLP-1 position - Fierce Biotech
Roche Media 6. Jan. 2026 Roche Clears Obesity Pill Legal Concerns With Structure Patent Agreement - BioSpace
Roche Media 1. Jan. 2026 AI-based Digital Pathology Market Intelligence Report, 2025-2035, Featuring Aiforia Technologies, Ibex Medical Analytics, Indica Labs, PathAI, Roche, Visiopharm and Many Other Key Players - ResearchAndMarkets.com - The AI Journal
Roche Media 26. Dez. 2025 Emerson and Roche Collaborate on Digital Modality Library for Pharmaceutical Development - Automation World
Roche Media 22. Dez. 2025 Roche Lunsumio VELO bags USFDA approval for subcutaneous use in follicular lymphoma - Medical Dialogues
Roche Media 22. Dez. 2025 ROG.SW News Today: Trump Drug Plan Boosts Roche Stock on December 22 - Meyka
Roche Media 11. Dez. 2025 Roche hails giredestrant effect in ER-positive early-stage breast cancer - The Pharma Letter
FierceBiotech 10. Dez. 2025 Roche links oral SERD to 30% breast cancer risk reduction in phase 3 adjuvant trial